| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Tamer I Khayal last filed a Form 4 in March 2025, as Chief Commercial Officer at TMDX. From May 2019 to March 2025, the filings on record show 0 open-market purchases and 43 sales. Tamer I Khayal's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Tamer I Khayal's trades have earned a middling insider score of 53/100 across 47 rated trades. Over a 12-month horizon, 46.8% of those trades were profitable, with an average 12-month return of -14.3%.
At the last filing, the largest reported position was 36,042 shares of TMDX. The TMDX filings lean toward selling, a net 402,101 shares.
Shares as reported in the last Form 4 for each company; the most recent is from March 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25, 2021 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE | 3,899 | $35.06 | $136,698.94 | -7.8% | -7.2% | -7.3% | |
| Mar 8, 2021 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE | 40,000 | $31.45 | $1,258,098.88 | -46.5% | - | - | |
| Jan 21, 2020 | TMDX Transmedics Group, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $20.02 | $100,100.00 | -9.8% | - | - |